COVID-19
Conditions
Interventions
None listed
Sponsors
Hirahata Clinic
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Japanese males and females aged 20 to 49 years old 2)Confirmed infection with COVID-19. 3)Those who have received a full explanation of the purpose and content of the study,are capable of consenting,understand the study well,and have voluntarily volunteered to participate in the study and have agreed to participate in the study in writing.
Exclusion criteria
Exclusion criteria: 1)Those who have a current or previous serious disease such as brain disease,malignant tumor,immunological disease,diabetes,liver disease hepatitis,renal disease,heart disease,etc.,thyroid disease,adrenal disease,or other metabolic disease 2)Those who have donated more than 200 mL of blood within 1 month or 400 mL of blood within 3 months prior to the date of consent. 3)Those who have difficulty in complying with the recording of various questionnaires. 4)Others who are judged as unsuitable as subjects by the principal investigator or sub-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Blood test 1-1.Plasma GSH,GSSG,low molecular weight thiol-bound GSH 1-2.Plasma malondialdehyde 1-3.Serum IL-6,TNF,IL-10 1-4.Peripheral blood including leukocyte image,AST,ALT,LDL,HDL,TG,FFA,BUN,creatinine,eGFR,Mg,Zn,Fe,ferritin,blood glucose,HbA1C,cortisol,25OHVD,vitamin C,high-sensitivity CRP,D Dimer 2.Questionnaire COVID-19 history,medical history,current medical history,family history,life history,indefinite complaints,etc. | — |
Secondary
| Measure | Time frame |
|---|---|
| 3.General measurements age,gender,height,weight,BMI,etc. 4.Vital signs | — |
Countries
Japan
Contacts
Public ContactToyoshi Urakami
Mitsubishi Corporation Life Sciences Limited Domestic Sales Group Nutrition Business Division
Outcome results
None listed